Fructose and Ethnic Differences Study (FED Study)
FED
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
In the UK, people of black West African and Caribbean's tend to have healthier blood cholesterol and blood fat levels, as well as lower incidence of heart disease/heart attack. But rates of heart disease are now rising in young African-American populations with diabetes, for the first time exceeding the rate in their white European-American peers. One possible culprit is the increasing consumption of fructose which can lead to high blood fat levels. Fructose is a natural sugar found in fruits and table sugar but is also used the food industry as an ingredient and sweetener. Because fructose intakes are lower in the UK than in North America we are studying the effect of fructose intake in UK black West African and Caribbean people, to understand if fructose intake is indeed a reason for these ethnic differences.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Dec 2012
Longer than P75 for not_applicable healthy
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 30, 2015
CompletedFirst Posted
Study publicly available on registry
August 27, 2015
CompletedMay 12, 2016
May 1, 2016
2.6 years
July 30, 2015
May 11, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postprandial triglyceride concentrations
At time 0 minutes participants were provided with a study breakfast which they were required to consume within a 15 minute period and subsequent blood samples were drawn at 15, 30, 45, 60, 90, 120, 180, 240, 300, 360 and 420 minutes. The lunch meal was consumed immediately following the 240 minute blood sample and final fructose/glucose drink was consumed immediately following the 420 minute blood sample. A final blood sample was drawn at 24 hours under fasting conditions.
0-420 minutes
Secondary Outcomes (5)
Postprandial glucose concentrations.
0-420 minutes
Serum and red blood cell cholesterol and non-cholesterol sterol concentrations
0 and 24-hour post treatment
Postprandial insulin concentrations
0-420 minutes
Postprandial c-peptide concentrations
0-420 minutes
Postprandial non-esterified fatty acid concentrations
0-420 minutes
Other Outcomes (2)
Ambulatory blood pressure
Blood pressure was measured every 20 minutes during the postprandial period.
Serum uric acid concentrations
Serum uric acid concentrations measured at 0, 15, 30, 45, 60, 90, 120, 180, 240, 300, 360 and 420 minutes.
Study Arms (2)
Dietary Sugar - Fructose
EXPERIMENTALEach participant consumed 20% daily caloric requirement as fructose.
Dietary Sugar - Glucose
ACTIVE COMPARATOREach participant consumed 20% daily caloric requirement as glucose.
Interventions
This study examined the effect of high intakes of fructose compared to high intakes of glucose in a randomized crossover design. The treatment was in replacement of 20% of the daily caloric requirements for either fructose or glucose for each individual.
Eligibility Criteria
You may qualify if:
- Self-reported healthy, confirmed by blood tests (i.e. liver enzymes, full blood count, lipids, glucose); ethnicity White European participants had at least 3 grandparents originating from countries of Europe and Black African participants had at least 3 grandparents originating primarily from countries of West Africa (Economic Community of West African States (ECOWAS) and central African countries (e.g. Cameroon, Uganda, etc).
You may not qualify if:
- fasting glucose in the diabetic range (fasting glucose \>7 mmol/l); hypertension (medically diagnosed or \>140/90 mm Hg at screening); hyperlipidaemia deemed to require immediate medical intervention (defined as: total cholesterol \>6.0 mmol/l; LDL-cholesterol \>4.5 mmol/l; fasting TG \>3 mmol/l).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Goff LM, Whyte MB, Samuel M, Harding SV. Significantly greater triglyceridemia in Black African compared to White European men following high added fructose and glucose feeding: a randomized crossover trial. Lipids Health Dis. 2016 Sep 2;15(1):145. doi: 10.1186/s12944-016-0315-3.
PMID: 27590876DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Scott V Harding, PhD
King's College London
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2015
First Posted
August 27, 2015
Study Start
December 1, 2012
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
May 12, 2016
Record last verified: 2016-05